JP Morgan Healthcare Week
Highlighted News About Biomica
Feb 4, 2026
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
The summit gathers leading drug developers and microbiome experts to discuss microbiome functionality, translation, clinical development, biomarker discovery, and manufacturing scale-up
Mar 17, 2025
Microbiome Times Partnering Forum
Biomica’s CEO, Dr. Elran Haber, is heading to Brussels this week for the Microbiome Times Partnering Forum – a key event for advancing microbiome-based therapeutics through strategic partnerships. More info & registration: www.microbiomeforum.com
Feb 27, 2025
MIXiii Health-Tech.IL 2025
Dr. Elran Haber, Biomica’s CEO, will attend MIXiii Health-Tech.IL 2025 on March 4-5 at ICC Jerusalem. This leading Israeli health-tech conference unites industry leaders, startups, and investors to explore innovations in personalized medicine, AI-driven drug development, cancer treatment, and more. More info & registration: www.mixiii.com